Trend Reports
Alcohol and Opioid Addiction
The Alcohol and Opioid Addiction Trend Report sponsored by Alkermes
Cardiology
Sanofi-aventis Atrial Fibrillation Data Brief (6 regional reports)
Dermatology
The Galderma Quality Report for Dermatology and Managed Care, Vol. II
​
Renew Advantage Aesthetic Dermatology and Plastic Surgery Loyalty Trend Report
Diabetes
The Novo Nordisk Diabetes Care Report: Partnering To Address Diabetes
Eye Care
The Eye Care Trend Report Supported By Allergan (Vol. I, II & III)
Gastroenterology
The Ferring Pharmaceuticals Gastroenterology Practice Management Report
Infertility
The Ferring Managed Care Trend Report for Infertility
Neurology & Senior Care
The Prescription Drug Benefit Cost and Plan Design Survey Report Provided by Takeda
​
The Ferring Managed Care Trend Report for Osteoarthritis
​
The Boehringer Ingelheim Pharmacy Benefits Report
​
The Boehringer Ingelheim Medicare Part D & Patient-Centered Medical Home Report
​
The UCB Parkinson’s Report: for Managed Care, Neurology & Senior Care Decision-Makers
​
Chronic Pain Care Trends: Perspectives from Managed Care, Providers, and Employers
​
The Multiple Sclerosis Trend Report: Perspectives from Managed Care, Providers, and Patients (sponsored by Teva Neuroscience & the National MS Society from 2006 to the present)
​
Sanofi-aventis Senior Care Digest Interdisciplinary Report: A Survey of Long-Term-Care Health Professionals
​
Biologics Trend Report Sponsored by UCB
Oncology
The Genentech Oncology Trend Report
Sanofi-aventis Oncology Cancer Care Report (5 regional reports)
Sanofi-aventis Atrial Fibrillation Data Brief (6 regional reports)
Newsletters
Allergy, Asthma
The American College of Allergy, Asthma & Immunology Practice Management Update
Dermatology
The Maruho Derma Report (newsletter for a few thousand Japanese dermatologists)
​
ACAAI Practice Management Update
​
The National Psoriasis Foundation
Reports on the 2016 AAD Meeting,
Supported by Novartis: The Role of IL-17 in Psoriasis
​
American Academy of Dermatology 77th Annual Meeting Highlights
Diabetes
Novo Nordisk Diabetes Care Report
​
Novo Nordisk Best Practices in Diabetes Management: Spotlight on Rapid-Acting Insulin Analogs
​
Novo Nordisk Best Practices in Diabetes Management: Spotlight on Long-Acting Analog Basal Insulins
​
Novo Nordisk Best Practices in Diabetes Management: NovoRapid Bolus Insulin Helps Diabetics Fast During Ramadan
​
Novo Nordisk Best Practices in Diabetes Management: Spotlight on Hypoglycemia
​
Novo Nordisk Best Practices in Diabetes Management: Rethinking the Role of Carbohydrates
​
Novo Nordisk Best Practices in Diabetes Management: With Guidance, Many Diabetes Patients Can Safely Fast During Ramadan
​
Novo Nordisk Best Practices in Diabetes Management: Strategies To Prevent and Manage Hypoglycemia
​
Novo Nordisk Best Practices in Diabetes Management: New Basal Insulin Offers Flexible Dosing, Other Benefits
​
Novo Nordisk Best Practices in Diabetes Management: Novo Nordisk’s Tresiba® Basal Insulin Enters the Saudi Arabia Market and is Well-Received
​
Novo Nordisk Best Practices in Diabetes Management: Insulin Degludec Tresiba® Will Help Keep Ramadan Fasting Safe
​
The Introduction of Tresiba® Adds A Powerful Tool to Diabetes Therapy: What Saudi Endocrinologists Are Saying About Tresiba®
​
Ramadan Expert opinion interview: Focus on Gliclazide supported by Servier
​
In Clinical Studies and Real-World Use, Tresiba® Boasts Its Status as Best Basal Insulin
​
TRESIBA® AND XULTOPHY® EQUIP ENDOCRINOLOGISTS WITH TWO POWERFUL DIABETES DRUGS: In Real-World Practice, Endocrinologists Praise Novo Nordisk’s Tresiba® and Xultophy
Senior Care
Management in Long-Term Care